i3 Pharmaceuticals, LLC
12 drugs in NADAC|12 Generic,0 Brand
i3 Pharmaceuticals, LLC lists 12 NDCs in the CMS NADAC file (12 generic, 0 brand), at an average NADAC of $1.86 per unit, with a week-over-week move of +1.3% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
12
12G / 0B
Avg Price / Unit
$1.8565
$0.15 – $9.15
Avg 7d Change
+1.29%
Across 11 drugs with changes
7d Activity
of 12 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Maraviroc market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
CCR5 Co-receptor Antagonist therapeutic class
Review the broader class where i3 Pharmaceuticals, LLC has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does i3 Pharmaceuticals, LLC make?
i3 Pharmaceuticals, LLC lists 12 NDCs in the CMS NADAC file — 12 generic and 0 brand products.
What is the average price of i3 Pharmaceuticals, LLC drugs?
The average NADAC across i3 Pharmaceuticals, LLC's portfolio is $1.8565 per unit, ranging from $0.1466 to $9.1496.
What types of drugs does i3 Pharmaceuticals, LLC make?
i3 Pharmaceuticals, LLC makes drugs across 10 FDA pharmacologic classes. The most common by NDC count are CCR5 Co-receptor Antagonist (2), Anticholinergic (2), Anti-anginal (2), Central alpha-2 Adrenergic Agonist (2), Azole Antifungal (1).
Has i3 Pharmaceuticals, LLC had any drug recalls?
No FDA enforcement recalls are matched to i3 Pharmaceuticals, LLC in the openFDA feed.
How has i3 Pharmaceuticals, LLC's pricing changed recently?
Over the past 7 days, 8 i3 Pharmaceuticals, LLC products rose and 3 fell, with a portfolio-wide average change of +1.3%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MARAVIROC 150 MG TABLET Maraviroc | $9.1496 per EA | — |
MARAVIROC 300 MG TABLET Maraviroc | $6.3391 per EA | +0.82% |
POSACONAZOLE DR 100 MG TABLET Posaconazole | $2.0315 per EA | +1.73% |
METHSCOPOLAMINE BROM 5 MG TAB methscopolamine bromide | $1.5316 per EA | +2.76% |
SELEGILINE HCL 5 MG TABLET Selegiline Hydrochloride | $0.7657 per EA | -3.39% |
ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET isosorbide dinitrate and hydralazine hydrochloride | $0.7138 per EA | +0.66% |
METHSCOPOLAMINE BROM 2.5 MG TB methscopolamine bromide | $0.6076 per EA | +10.34% |
CLINDAMYCIN PHOS 1% PLEDGET Clindamycin phosphate topical | $0.2854 per EA | +0.50% |
RANOLAZINE ER 1,000 MG TABLET RANOLAZINE | $0.2743 per EA | -1.58% |
GUANFACINE 2 MG TABLET Gaunfacine | $0.2673 per EA | -1.79% |
RANOLAZINE ER 500 MG TABLET RANOLAZINE | $0.1649 per EA | +2.51% |
GUANFACINE 1 MG TABLET Gaunfacine | $0.1466 per EA | +1.62% |